On invitation from the Henry Royce Institute (UK's National Institute for
Advanced Materials Research and Innovation) to participate.
Copner Biotech's CEO presents our state of the art biofabrication technology at the
Biosculpt UK-India Conference hosted by the Indian Institute of Science (IISc) Bangalore
Copner Biotech are pleased to announce our participation in a collaborative biofabrication research programme in conjunction with Northampton and Loughborough Universities.
Professor Lee Machado of Northampton University "..Advancing 4D Bioprinting for Functional Disease Models and Therapeutic Discovery
is a collaborative project between the University of Northampton, Copner Biotech,
and Loughborough University to expand state-of-the-art 4D bioprinting technology
for biomedical research. Building on earlier work establishing 3D bioprinting for sarcoma,
this project deploys Copner Biotech’s GRAPE S1 4D bioprinter to create dynamic,
physiologically relevant in-vitro models for immune disorders, cancer, and therapeutic testing..."
Copner Biotech's CEO and CTO attended Victoria House London for this inspiring Life Sciences event,
at which we were able to futher our mission to form collaborations and export activities to China ..
A pleasure to meet with our distributor CliniSciences promoting our state of the art 3D Cell Culture
Scaffolds at their stand at Lab Innovations NEC ..
Copner Biotech were honoured to receive the invitation from His Excellency Jeroen Cooreman Ambassador of the Kingdom of Belgium to the United Kingdom
to attend the Life Sciences Wallonia Business Forum held at the Belgian Embassy London.
Copner Biotech are pleased to announce that we have been awarded the "Bioprinter Innovation Excellence Award 2025"...
Copner Biotech's CEO and CTO attend Keele University to demonstrate our 3D Cell Culture and Biofabrication technology;
many thanks to Professor Ying Yang for organising this event and being such a great host...
Copner Biotech are proud to be collaborating with Glasgow University on this cutting
edge research into treatments for Prostate Cancer...
Copner Biotech awarded three Business Development Grants from Blaenau Gwent.
These grants will be instrumental in upgrading our current extrusion bioprinter, the GRAPE-S1,
to include a built-in clean room environment and new software features. Additionally,
the funding will assist us to consolidate our intellectual property portfolio to include
European and US patents to run along side our UK patents.
Copner Biotech's CFO Elizabeth Copner FCCA FMAAT selected as a finalist for the Chief Financial Officer/Finance Director of the Year; sponsored by Principality Building Society.
Copner Biotech's CTO and CFO honoured to be invited to the St David's Day Reception fostering ties and opportunities
between Denmark and Wales held at the British Embassy Copenhagen.
Copner Biotech's product portfolio as featured in Beijing news media; leads the way in 3D cell culture and tissue regeneration...
The company’s new proprietary GRAPE® 3D modeling format enables users to model and
print highly accurate 3D constructs with high batch consistency. With Copner Biotech’s
next-generation 3D modeling software, users can directly design and create complex
microstructures suitable for 3D cell culture and tissue engineering applications
GRAPE® Technology - Renderable Biofabrication®